|
|
||||||||
|
FIGURE 3. Chemical structures of DTPA- and DOTA-modified somatostatin-based peptides for targeted radiotherapy. (A) DTPA0-octreotide. (B) DOTA0-Tyr3-octreotide (DOTATOC). (C) DOTA0-Tyr3-Thr8-octreotide (DOTATATE). (D) DOTA0-2-Nal-Tyr3-Thr-NH28-octreotide (DOTA-lanreotide).
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |